Is intraperitoneal dextran 70 safe for routine gynecologic use?
The routine use of intraperitoneal 32% dextran 70 has been suggested as an adjuvant to prevent postsurgical pelvic adhesions. Two hundred thirty-four women received an antiadhesion regimen consisting of intraperitoneal 32% dextran 70, dexamethasone, and promethazine. Ten women (4%) experienced spontaneous leakage of the dextran-peritoneal fluid mixture through their abdominal incisions. Painless bilateral swelling of the labia was noted in 18 women (8%). Mild abdominal bloating and weight gain of from 2.5 to 11 pounds were common. No anaphylactic reactions, peritonitis, or wound infections were experienced by any woman. Intraperitoneal dextran 70 appears to be a safe, well-tolerated antiadhesion adjuvant for routine use in gynecologic operations.
D M
DM
Magyar
M F
MF
Hayes
N J
NJ
Spirtos
M E
ME
Hull
K S
KS
Moghissi
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use*; D004322:Drainage; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery; D006801:Humans; D007247:Infertility, Female / Q000601:surgery*; D010532:Peritoneal Diseases / Q000517:prevention & control*; D011183:Postoperative Complications; D011292:Premedication; D011398:Promethazine / Q000008:administration & dosage; D012996:Solutions; D000267:Tissue Adhesions / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D003911:Dextrans; D012996:Solutions; D003907:Dexamethasone; D011398:Promethazine